Clinical Nutrition Segmentation
The market is segmented based on product into infant nutrition, parenteral nutrition, and enteral nutrition, out of which, the infant nutrition segment is anticipated to grab the largest share by the end of 2037 on account of increased number of malnourished babies and growing premature births. Moreover, increasing government approval of new infant nutrition products globally is also projected to contribute to the growth of the segment during the forecast period.
On the basis of application, the cancer segment in the global clinical nutrition market is projected to grow with a significant CAGR over the forecast period. The growth of the segment can be attributed to the fact that cancer patients are suffering from nutritional deficiency that arises due to various cancer treatments including radiation therapy, chemotherapy, stem cell transplant, and others. As a result, a considerable portion of the population with cancer on a global level is expected to drive the growth of the market over the forecast period.
Based on end-user, the paediatric segment holds the largest share in the global clinical nutrition market on the back of growing concerns and awareness for malnutrition.
Our in-depth analysis of the global market includes the following segments
|
By Products |
|
|
By Application |
|
|
By End-User |
|
